NSAIDs in axial spondyloarthritis: to be continued ...?

被引:6
作者
Varkas, G. [1 ,2 ]
Van den Bosch, F. [1 ]
机构
[1] Ghent Univ Hosp, Dept Rheumatol, De Pintelaan 185, B-9000 Ghent, Belgium
[2] Univ Ghent, Mol Immunol & Inflammat Unit, VIB Inflammat Res Ctr, Ghent, Belgium
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TOTAL HIP-ARTHROPLASTY; ANKYLOSING-SPONDYLITIS; HETEROTOPIC OSSIFICATION; RADIOGRAPHIC PROGRESSION; DOUBLE-BLIND; TRIAL; INDOMETHACIN; PROPHYLAXIS; CELECOXIB;
D O I
10.1136/annrheumdis-2015-208194
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1423 / 1425
页数:3
相关论文
共 33 条
[1]   NO EFFECTS OF PIROXICAM ON OSTEOPENIA AND RECOVERY AFTER COLLES FRACTURE - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROSPECTIVE TRIAL [J].
ADOLPHSON, P ;
ABBASZADEGAN, H ;
JONSSON, U ;
DALEN, N ;
SJOBERG, HE ;
KALEN, S .
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 1993, 112 (03) :127-130
[2]   Increased mortality in ankylosing spondylitis is related to disease activity [J].
Bakland, Gunnstein ;
Gran, Jan Tore ;
Nossent, Johannes C. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (11) :1921-1925
[3]   Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis [J].
Baraliakos, Xenofon ;
Haibel, Hildrun ;
Listing, Joachim ;
Sieper, Joachim ;
Braun, Juergen .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (04) :710-715
[4]   Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials [J].
Bhala, N. ;
Emberson, J. ;
Merhi, A. ;
Abramson, S. ;
Arber, N. ;
Baron, J. A. ;
Bombardier, C. ;
Cannon, C. ;
Farkouh, M. E. ;
FitzGerald, G. A. ;
Goss, P. ;
Halls, H. ;
Hawk, E. ;
Hawkey, C. ;
Hennekens, C. ;
Hochberg, M. ;
Holland, L. E. ;
Kearney, P. M. ;
Laine, L. ;
Lanas, A. ;
Lance, P. ;
Laupacis, A. ;
Oates, J. ;
Patrono, C. ;
Schnitzer, T. J. ;
Solomon, S. ;
Tugwell, P. ;
Wilson, K. ;
Wittes, J. ;
Baigent, C. ;
Adelowo, O. ;
Aisen, P. ;
Al-Quorain, A. ;
Altman, R. ;
Bakris, G. ;
Baumgartner, H. ;
Bresee, C. ;
Carducci, M. ;
Chang, D-M. ;
Chou, C-T. ;
Clegg, D. ;
Cudkowicz, M. ;
Doody, L. ;
El Miedany, Y. ;
Falandry, C. ;
Farley, J. ;
Ford, L. ;
GarciLosa, M. ;
Gonzalez-Ortiz, M. ;
Haghighi, M. .
LANCET, 2013, 382 (9894) :769-779
[5]  
BOERSMA JW, 1976, SCAND J RHEUMATOL, V5, P60
[6]   2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis [J].
Braun, J. ;
van den Berg, R. ;
Baraliakos, X. ;
Boehm, H. ;
Burgos-Vargas, R. ;
Collantes-Estevez, E. ;
Dagfinrud, H. ;
Dijkmans, B. ;
Dougados, M. ;
Emery, P. ;
Geher, P. ;
Hammoudeh, M. ;
Inman, R. D. ;
Jongkees, M. ;
Khan, M. A. ;
Kiltz, U. ;
Kvien, T. K. ;
Leirisalo-Repo, M. ;
Maksymowych, W. P. ;
Olivieri, I. ;
Pavelka, K. ;
Sieper, J. ;
Stanislawska-Biernat, E. ;
Wendling, D. ;
Ozgocmen, S. ;
van Drogen, C. ;
van Royen, B. J. ;
van der Heijde, D. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) :896-904
[7]   Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion [J].
Burd, TA ;
Hughes, MS ;
Anglen, JO .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2003, 85B (05) :700-705
[8]   Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison [J].
Cannon, Christopher P. ;
Curtis, Sean P. ;
FitzGerald, Garret A. ;
Krum, Henry ;
Kaur, Amarjot ;
Bolognese, James A. ;
Reicin, Alise S. ;
Bombardier, Claire ;
Weinblatt, Michael E. ;
van der Heijde, Desiree ;
Erdmann, Erland ;
Laine, Loren .
LANCET, 2006, 368 (9549) :1771-1781
[9]  
DAVIS TRC, 1988, BRIT J CLIN PRACT, V42, P184
[10]   Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial [J].
Dougados, M ;
Gueguen, A ;
Nakache, JP ;
Velicitat, P ;
Veys, EM ;
Zeidler, H ;
Calin, A .
RHEUMATOLOGY, 1999, 38 (03) :235-244